277 par Pill — WHITE;ORANGE CAPSULE, 16mm — Fluoxetine

Imprint	277 / par
Colour	WHITE;ORANGE
Shape	CAPSULE
Size	16
Strength	OLANZAPINE 3 mg;FLUOXETINE HYDROCHLORIDE 25 mg
Dosage form	Capsule
Manufacturer	Par Pharmaceutical Inc.
NDC	49884-277
Schedule	—
Availability	Prescription only
Ingredients	OLANZAPINE[OLANZAPINE];FLUOXETINE HYDROCHLORIDE[FLUOXETINE]

What does this imprint mean?

The imprint "277 par" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Fluoxetine

Uses and warnings

BOXED WARNING: BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glaucoma in susceptible patients - Hyponatremia/SIADH - QT interval prolongation - Cognitive and motor impairment potential --- | BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glauc

Fluoxetine is indicated for: - "Acute and maintenance treatment of Major Depressive Disorder" - "Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)" - "Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa" - "Acute treatment of Panic Disorder, with or without agoraphobia" ---

Read the full drug profile →